Beamtree Holdings Ltd
ASX:BMT

Watchlist Manager
Beamtree Holdings Ltd Logo
Beamtree Holdings Ltd
ASX:BMT
Watchlist
Price: 0.21 AUD Market Closed
Market Cap: 61m AUD

Beamtree Holdings Ltd
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Beamtree Holdings Ltd
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Beamtree Holdings Ltd
ASX:BMT
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
4DMedical Ltd
ASX:4DX
Non-Reccuring Items
-AU$659.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pro Medicus Ltd
ASX:PME
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alcidion Group Ltd
ASX:ALC
Non-Reccuring Items
-AU$118k
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Artrya Ltd
ASX:AYA
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Beamtree Holdings Ltd
Glance View

Market Cap
60.9m AUD
Industry
Health Care

Beamtree Holdings Ltd. is an Australian healthcare technology company. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-06-06. The firm work with health organizations to capture, manage and leverage human skills. The firm enables healthcare providers to access information, automate wherever possible and make informed decisions. Its products and services include picq, RippleDown Expert, RippleDown Auditor, RISQ, Q Coding platform and codexpert. RippleDown Expert automatically applies clinical solutions to generate patient-centric reports. Its Q Coding platform provides an end-to-end workflow suite for clinical coding, grouping, reporting and auditing. RippleDown Auditor automates real-time reviews of all data in pathology. Codexpert is used in clinical coding classification reference. RISQ improves identification and benchmarking better patient care.

BMT Intrinsic Value
0.44 AUD
Undervaluation 52%
Intrinsic Value
Price

See Also

Back to Top